Jame Abraham, MD, FACP, of the Cleveland Clinic, offers his thoughts on abstract S1-09, "A phase Ib study of pembrolizumab (MK-3475) in patients with advanced triple-negative breast cancer," presented by Rita Nanda, MD.
Matthew J. Ellis, MD, PhD, of the Baylor College of Medicine, offers a brief synopsis of his plenary lecture, "Genome-Directed Therapeutics for Endocrine Therapy–Resistant Estrogen...
William M. Sikov, MD, of Women and Infants Hospital, discusses abstract S4-05, ...
Matthew J. Ellis, MD, PhD, of the Baylor College of Medicine discusses with Harold J. Burstein, MD, PhD, of the Dana-Farber Cancer Institute genome-directed therap...
Hope S. Rugo, MD, of the University of California, San Francisco, discusses abstract S5-08,
Gunter von Minckwitz, MD, of the University of Frankfurt, offers his thoughts on abstract S3-04,
